FIELD: organic chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely to a method (options) for the production of methane-sulfonate salt of a compound of the formula (IV), including a stage A of bringing into interaction of a compound of the formula (A-1) with a compound of the formula (A-2) in the presence of a suitable base with subsequent precipitation and isolation of a compound of the formula (I) from a reaction solution by introduction into the reaction solution of an aqueous organic solvent, a stage B of bringing into interaction of the compound of the formula (I), obtained at the stage A, with a compound of the formula (II-A), where R1 is C1-6alkyl group or C6aryl group, and X is a halogen atom, in the presence of a suitable base and water to obtain a compound of the formula (III), where R1 is the same group as described above, a stage C of bringing into interaction of the compound of the formula (III), obtained at the stage B without isolation, with cyclopropylamine with subsequent precipitation and isolation of a compound of the formula (IV) by introduction into the reaction solution of an aqueous organic solution, and a stage D of conversion of the compound of the formula (IV), obtained at the stage C, into methane-sulfonate salt of the compound of the formula (IV).
EFFECT: method for the production of methane-sulfonate salt of a compound of the formula (IV), showing antitumor activity, is developed, providing high yield and high purity of the target compound.
, , , , ,
3 cl, 11 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTICANCER THERAPEUTIC AGENT | 2012 |
|
RU2580609C2 |
DIHYDROPYRAZOLOPYRAZINONE DERIVATIVE WITH MGAT-2 INHIBITORY ACTIVITY | 2020 |
|
RU2803743C2 |
PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE DERIVATIVE | 2010 |
|
RU2548673C2 |
METHOD AND COMPOUND USEFUL IN PREPARING OREXIN-2 RECEPTOR ANTAGONIST, AND LEMBOREXANT CONTAINING SMALL AMOUNT OF IMPURITIES | 2020 |
|
RU2823998C2 |
CONDENSED CYCLIC DERIVATIVE WITH INHIBITORY ACTIVITY AGAINST MGAT-2 | 2018 |
|
RU2770437C2 |
METHOD OF PRODUCING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND INTERMEDIATE COMPOUND THEREOF | 2016 |
|
RU2717830C2 |
ANTICANCER DRUG FOR THYROID CANCER | 2007 |
|
RU2448708C2 |
FURO[3,2-C]PYRIDINE OR THIENO[3,2-C]PYRIDINE DERIVATIVES USEFUL IN TREATING NOCTURIA | 2015 |
|
RU2700411C2 |
COPOLYMER, RUBBER MIXTURE, CROSS-LINKED RUBBER MIXTURE AND TYRE | 2012 |
|
RU2553474C1 |
DOUBLE-HEADED PROTEASE INHIBITOR | 2018 |
|
RU2780491C2 |
Authors
Dates
2022-12-14—Published
2015-08-26—Filed